SCHEMBL269510

SCHEMBL269510

OC1CCCc2ccccc2-c2ccccc21

nearest known ligand 0.48

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.43
HTR2A P28223 1/20 0.43
HPGD P15428 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CYP2A6 P11509 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
BLM P54132 1/20 0.41
TSHR P16473 1/20 0.41
HTT P42858 1/20 0.40
ALDH1A1 P00352 1/20 0.39
CHRNA7 P36544 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7535293 0.89 HTR2A (0.46) IDO1HTR2A
SCHEMBL29449692 0.84 IDO1 (0.53) IDO1BLMTSHRHTTALDH1A1
SCHEMBL59026 0.84 IDO1 (0.53) IDO1BLMTSHRHTTALDH1A1
SCHEMBL3596545 0.84 IDO1 (0.53) IDO1BLMTSHRHTTALDH1A1
SCHEMBL3583014 0.84 IDO1 (0.53) IDO1BLMTSHRHTTALDH1A1
Bromide SCHEMBL9033434 0.82 IDO1 (0.52) IDO1BLMTSHRHTTALDH1A1
Hydrochloric Acid SCHEMBL22770167 0.82 IDO1 (0.55) IDO1BLMTSHRHTTALDH1A1
Water SCHEMBL28334394 0.82 IDO1 (0.52) IDO1BLMTSHRHTTALDH1A1
Benzene SCHEMBL28873131 0.82 IDO1 (0.52) IDO1BLMTSHRHTTALDH1A1
SCHEMBL15291325 0.79 CYP2A6 (0.52) HPGDL3MBTL1CYP2A6MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116497102-A Adaptors, methods for characterizing polynucleotides of interest and uses thereof 成都齐碳科技有限公司 2023-07-28 CN disclosed
CN-107002151-B Method of delivering an analyte to a transmembrane pore 牛津纳米孔技术公司 2022-04-01 CN disclosed
CN-114107457-A Method of delivering an analyte to a transmembrane pore 牛津纳米孔技术公司 2022-03-01 CN disclosed
CN-113981055-A Nanopore RNA characterization method 牛津纳米孔技术公司 2022-01-28 CN disclosed
CN-107109489-B Nanopore RNA characterization method 牛津纳米孔技术公司 2021-11-30 CN disclosed
EP-2907525-B1 DIBENZOCYCLOOCTENE-COMPOUNDS FOR BIOORTHOGONAL REACTIONS UNIV GEORGIA (US) 2018-05-16 EP disclosed
US-9932297-B2 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2018-04-03 US disclosed
US-20170320815-A1 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 2017-11-09 US disclosed
US-9725405-B2 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2017-08-08 US disclosed
US-20160159732-A1 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 2016-06-09 US disclosed
EP-2907525-A2 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds University Of Georgia Research Foundation, Inc. (US) 2015-08-19 EP disclosed
US-20150126706-A1 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. 2015-05-07 US disclosed
US-8940859-B2 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2015-01-27 US disclosed
US-20120322974-A9 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2012-12-20 US disclosed
US-20120172575-A1 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2012-07-05 US disclosed
US-8133515-B2 Alkynes and methods of reacting alkynes with 1,3-dipole-functional compounds UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2012-03-13 US disclosed
US-20120040011-A9 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2012-02-16 US disclosed
US-20100297250-A1 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2010-11-25 US disclosed
EP-2222341-A1 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS University Of Georgia Research Foundation, Inc. (US) 2010-09-01 EP disclosed
WO-2009067663-A1 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2009-05-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100297250-A1 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS ALG1, ST3GAL3, B3GNT2 IDO1 395/4885HTR2A 2987/4885HPGD 633/4885
US-20120040011-A9 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS ALG1, ST3GAL3, B3GNT2 IDO1 395/4885HTR2A 2987/4885HPGD 633/4885
US-20170320815-A1 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS ALG1, ST3GAL3, B3GNT2 IDO1 395/4885HTR2A 2987/4885HPGD 633/4885
US-20120322974-A9 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS ALG1, ST3GAL3, B3GNT2 IDO1 395/4885HTR2A 2987/4885HPGD 633/4885
US-20150126706-A1 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS ALG1, ST3GAL3, B3GNT2 IDO1 395/4885HTR2A 2987/4885HPGD 633/4885
US-20120172575-A1 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS ALG1, ST3GAL3, B3GNT2 IDO1 395/4885HTR2A 2987/4885HPGD 633/4885
US-20160159732-A1 ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS ALG1, ST3GAL3, B3GNT2 IDO1 395/4885HTR2A 2987/4885HPGD 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.